Arraystar CircRNA Array Services >> |
|
|
|
Title |
Author |
Journal |
Year |
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output |
Zhao Q, et al. |
Cell |
2020 |
Circular RNAs as biomarkers in liquid biopsy in colorectal cancer |
Valladares-Ayerbes M, et al. |
Journal of Clinical Oncology |
2020 |
Extracellular Vesicle-Mediated Delivery of CircSCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models |
Yang L, et al. |
Circulation |
2020 |
1972P Circular RNA is associated with enzalutamide resistant prostate cancer |
Lim M C J, et al. |
Annals of Oncology |
2020 |
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 |
Xu J, et al. |
Signal Transduction and Targeted Therapy |
2020 |
The nuclear DICER–circular RNA complex drives the deregulation of the glioblastoma cell microRNAome |
Bronisz A, et al. |
Science Advances |
2020 |
A psychiatric disease-related circular RNA controls synaptic gene expression and cognition |
Zimmerman A J, et al. |
Molecular Psychiatry |
2020 |
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer |
Yang H, et al. |
Molecular Cancer |
2020 |
Comparative Analysis of Circulating Non-Coding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury |
Schulte C, et al. |
Circulation research |
2019 |
N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis |
Chen R, et al. |
Nature Communications |
2019 |
Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis |
Garikipati V., et al. |
Nature Communications |
2019 |
FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition |
Cherubini A, et al |
Nucleic acids research |
2019 |
Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals |
Xue D, et al. |
Molecular cancer |
2019 |
circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling |
Hu X, et al. |
Molecular cancer |
2019 |